The success of pharmaceutical companies in developing drugs for treating and curing medical conditions is largely dependent ...

This is a continuation of an earlier article in this issue, where the importance of ‘Data Integrity’ was elaborated. The opinions are generalized to a certain extent, only to drive home the point and ...

How has the pandemic changed the way Pharma is looking at data integrity in 2024? Data integrity has always been a big topic in pharma. You know, the idea that research and testing has been clearly ...

As the race to deliver personalised engagement at scale heats up, artificial intelligence (AI) has become the critical differentiator for pharma companies, turning vast data streams into actionable ...

Commerce minister Piyush Goyal had recently said that data exclusivity could help attract R&D investments in the pharmaceuticals sector. However, data exclusivity to originator firms could facilitate ...

Doron Aspitz is the CEO of Verix, a leading provider of AI commercial operations enhancement platforms for the pharmaceutical industry. To bring life-changing medicines to as many patients as possible ...

Jay Richetelli, VP of Client Partnerships at DeepIntent, shares how artificial intelligence (AI) is transforming pharma marketing. He breaks down how generative Al is revolutionizing the creative ...

aTyr Pharma's pivotal data readouts in 2025 for SSc-ILD (Phase 2) and pulmonary sarcoidosis (Phase 3) could significantly impact its market potential and approval prospects. Efzofitimod shows promise ...

The National Pharmaceutical Pricing Authority (NPPA) conducted a pre-bid meeting on Tuesday for the tender regarding the ...

Netrin-1 blockade with NP137 confirmed as a clinical strategy in oncology to alleviate resistance to standard treatments Given its impact on EMT and excellent safety profile, NP137 is perfectly ...